Skip to main content
Fig. 3 | BMC Pulmonary Medicine

Fig. 3

From: The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study

Fig. 3

Point prevalence of COPD (diagnosed by spirometry) by GOLD stage. The prevalence of various GOLD stages of COPD was calculated per 1000 persons and expressed with 95% confidence intervals, for COPD diagnosed by spirometry (confirmed by spirometry results based on GOLD Guidelines (2011), i.e. FEV1/FVC <  0.70). There were no respondents diagnosed with COPD III or IV GOLD stages in this study

Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us